Who owns GLAUKOS Corp (GKOS)? Elite investor 13F holders

6 tracked elite investors reported holding GLAUKOS Corp as of 2026-06-30, including D.E. Shaw, Renaissance Technologies LLC, Polen Capital Management, Bridgewater Associates, GAMCO. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

6 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Health Care Equipment & Services

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
D.E. ShawGLAUKOS CORPSHARE2026-06-302026-08-14 00:00:007992036.00 USD57184.000000SharesreduceOriginal filing
Renaissance Technologies LLCGLAUKOS CORPSHARE2026-06-302026-08-13 00:00:0020571554.00 USD147192.000000SharesaddOriginal filing
Polen Capital ManagementGLAUKOS CORPSHARE2026-06-302026-08-04 00:00:00673364.00 USD4818.000000SharesbuyOriginal filing
Bridgewater AssociatesGLAUKOS CORPSHARE2026-06-302026-08-14 00:00:00462606.00 USD3310.000000SharesbuyOriginal filing
GAMCOGLAUKOS CORPSHARE2026-06-302026-08-12 00:00:00452543.00 USD3238.000000SharesreduceOriginal filing
Ancora Advisors / Ancora HoldingsGLAUKOS CORPSHARE2026-06-302026-08-14 00:00:001677.00 USD12.000000SharesholdOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown